Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Safety and efficacy of subcutaneous hepatitis B immunoglobulin after liver transplantation: an open single-arm prospective study.

Di Costanzo GG, Lanza AG, Picciotto FP, Imparato M, Migliaccio C, De Luca M, Scuderi V, Tortora R, Cordone G, Utech W, Calise F.

Am J Transplant. 2013 Feb;13(2):348-52. doi: 10.1111/j.1600-6143.2012.04319.x. Epub 2012 Nov 8.

2.

Antibody to hepatitis B surface antigen trough levels and half-lives do not differ after intravenous and intramuscular hepatitis B immunoglobulin administration after liver transplantation.

Hooman N, Rifai K, Hadem J, Vaske B, Philipp G, Priess A, Klempnauer J, Tillmann HL, Manns MP, Rosenau J.

Liver Transpl. 2008 Apr;14(4):435-42. doi: 10.1002/lt.21343.

3.

[Prevention and treatment of hepatitis B virus reinfection after liver transplantation].

Liu J, Wu GC, Zhang ZT, Wu P, Zhang D, Sun MC, Gao DC, Wang Y, Jia JD, Wang BE.

Zhonghua Wai Ke Za Zhi. 2005 Aug 1;43(15):976-9. Chinese.

PMID:
16194352
4.

Pharmacokinetics and efficacy of intravenous or intramuscular hepatitis B immunoglobulins in prophylaxis of hepatitis B after liver transplantation.

Marzano A, Marengo A, Andreone P, Volpes R, Canova D, Cursaro C, Riili A, Fiorentino B, Bacci M, Guazzini S, Burra P.

Minerva Med. 2010 Dec;101(6):373-83.

PMID:
21196896
6.

Early Introduction of Subcutaneous Hepatitis B Immunoglobulin Following Liver Transplantation for Hepatitis B Virus Infection: A Prospective, Multicenter Study.

De Simone P, Romagnoli R, Tandoi F, Carrai P, Ercolani G, Peri E, Zamboni F, Mameli L, Di Benedetto F, Cillo U, De Carlis L, Lauterio A, Lupo L, Tisone G, Prieto M, Loinaz C, Mas A, Suddle A, Mutimer D, Roche B, Wartenberg-Demand A, Niemann G, Böhm H, Samuel D.

Transplantation. 2016 Jul;100(7):1507-12. doi: 10.1097/TP.0000000000001171. Erratum in: Transplantation. 2017 May;101(5):e193.

7.

Compliance and tolerability of subcutaneous hepatitis B immunoglobulin self-administration in liver transplant patients: a prospective, observational, multicenter study.

Klein CG, Cicinnati V, Schmidt H, Ganten T, Scherer MN, Braun F, Zeuzem S, Wartenberg-Demand A, Niemann G, Schmeidl R, Beckebaum S.

Ann Transplant. 2013 Dec 13;18:677-84. doi: 10.12659/AOT.889269.

8.
10.

Efficacy of maintenance subcutaneous hepatitis B immune globulin (HBIG) post-transplant for prophylaxis against hepatitis B recurrence.

Singham J, Greanya ED, Lau K, Erb SR, Partovi N, Yoshida EM.

Ann Hepatol. 2010 Apr-Jun;9(2):166-71.

PMID:
20526010
12.
13.

Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation.

Gane EJ, Angus PW, Strasser S, Crawford DH, Ring J, Jeffrey GP, McCaughan GW; Australasian Liver Transplant Study Group.

Gastroenterology. 2007 Mar;132(3):931-7. Epub 2007 Jan 5.

PMID:
17383422
14.

Subcutaneous administration of hepatitis B immune globulin in combination with lamivudine following orthotopic liver transplantation: effective prophylaxis against recurrence.

Powell JJ, Apiratpracha W, Partovi N, Erb SR, Scudamore CH, Steinbrecher UP, Buczkowski AK, Chung SW, Yoshida EM.

Clin Transplant. 2006 Jul-Aug;20(4):524-5.

PMID:
16842532
15.

Prevention of lamivudine-resistant hepatitis B recurrence after liver transplantation with entecavir plus tenofovir combination therapy and perioperative hepatitis B immunoglobulin only.

Karlas T, Hartmann J, Weimann A, Maier M, Bartels M, Jonas S, Mössner J, Berg T, Tillmann HL, Wiegand J.

Transpl Infect Dis. 2011 Jun;13(3):299-302. doi: 10.1111/j.1399-3062.2010.00591.x. Epub 2010 Dec 16.

PMID:
21159112
16.

Hepatitis B prophylaxis in living donor liver transplantation: single center experience.

Yaprak O, Dayangac M, Balci D, Bas K, Yuzer Y, Tokat Y.

Hepatogastroenterology. 2010 Sep-Oct;57(102-103):1178-82.

PMID:
21410054
17.

Effectiveness of low-dose intramuscular anti-VHB immune globulin in the prophylaxis of viral B hepatitis reinfection after liver transplantation: preliminary report.

Alonso I, Herreros de Tejada A, Moreno JM, Rubio E, Lucena JL, De la Revilla J, Sánchez Turrión V, Gomez A, Lopez J, Cuervas-Mons V.

Transplant Proc. 2003 Aug;35(5):1850-1.

PMID:
12962821
18.

Anti-HBs response to hepatitis B immunoglobulin prophylaxis in liver transplant recipients.

Varghese J, Reddy MS, Cherian T, Vijaya S, Jayanthi V, Rela M.

Indian J Gastroenterol. 2014 May;33(3):226-30. doi: 10.1007/s12664-014-0457-z. Epub 2014 Apr 24.

PMID:
24760685
19.

Protective antibody levels and dose requirements for IV 5% Nabi Hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B-induced end stage liver disease.

Dickson RC, Terrault NA, Ishitani M, Reddy KR, Sheiner P, Luketic V, Soldevila-Pico C, Fried M, Jensen D, Brown RS Jr, Horwith G, Brundage R, Lok A.

Liver Transpl. 2006 Jan;12(1):124-33.

20.

Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis.

Angelico M, Di Paolo D, Trinito MO, Petrolati A, Araco A, Zazza S, Lionetti R, Casciani CU, Tisone G.

Hepatology. 2002 Jan;35(1):176-81.

PMID:
11786974

Supplemental Content

Support Center